Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ac-2nal-4cpa-3pal-ser-4aph(hydroorotyl)-4aph(carbamoyl)-leu-ilys-pro-ala-nh2
2. Acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ilys-prolyl-alaninamide
3. Degarelix
4. Fe 200486
5. Fe-200486
6. Fe200486
7. Firmagon
8. Gonax
9. Uglypeptide1
1. 934016-19-0
2. Gonax
3. Firmagon
4. Ext215f4zu
5. Degarelix (as Acetate)
6. Degarelix Acetate Hydrate
7. Fe-200486
8. Degarelix Acetate (jan)
9. N-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-4-[[[(4s)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-l-phenylalanyl-4-[(aminocarbonyl)amino]-d-phenylalanyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-d-alaninamide,monoacetate
10. Asp3550
11. Fe200486
12. Unii-ext215f4zu
13. Fe200486 (free Base)
14. Firmagon (tn)
15. Degarelix Monoacetate
16. Chembl2028987
17. Degarelix Acetate Anhydrous
18. Dtxsid201027699
19. Asp-3550
20. Mfcd16879085
21. Degarelix Monoacetate Anhydrous
22. Degarelix (acetate) Pound>>fe 200486
23. Degarelix Acetate(214766-78-6 Free Base)
24. D09400
25. Q27277419
26. D-alaninamide, N-acetyl-3-(naphtalen-2-yl)-d-alanyl-4-chloro-d-phenylalanyl-3-(pyridin-3-yl)-d-alanyl-l-seryl-4-((((4s)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-l-phenylalanyl-4-(carbamoylamino)-d-phenylalanyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl-, Acetate (1:1)
Molecular Weight | 1692.3 g/mol |
---|---|
Molecular Formula | C84H107ClN18O18 |
Hydrogen Bond Donor Count | 18 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 41 |
Exact Mass | 1690.7699263 g/mol |
Monoisotopic Mass | 1690.7699263 g/mol |
Topological Polar Surface Area | 550 Ų |
Heavy Atom Count | 121 |
Formal Charge | 0 |
Complexity | 3420 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 11 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
FIRMAGON is a gonadotrophin releasing hormone (GnRH) antagonist indicated:
- for treatment of adult male patients with advanced hormone-dependent prostate cancer .
- for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
- as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer .
L02BX02
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38904
Submission : 2023-09-27
Status : Active
Type : II
NDC Package Code : 14403-0019
Start Marketing Date : 2024-06-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-09-08
Pay. Date : 2020-08-07
DMF Number : 35078
Submission : 2020-08-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-06-27
Pay. Date : 2022-12-05
DMF Number : 36499
Submission : 2023-01-19
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-09
Pay. Date : 2019-03-01
DMF Number : 33550
Submission : 2019-02-21
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-02-24
Pay. Date : 2021-09-17
DMF Number : 36216
Submission : 2022-01-27
Status : Active
Type : II
NDC Package Code : 66529-0017
Start Marketing Date : 2019-09-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-02-08
Pay. Date : 2020-10-19
DMF Number : 35257
Submission : 2020-10-15
Status : Active
Type : II
NDC Package Code : 61662-0015
Start Marketing Date : 2020-01-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37005
Submission : 2023-04-19
Status : Active
Type : II
NDC Package Code : 42973-343
Start Marketing Date : 2022-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : FIRMAGON
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 80 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : FIRMAGON
Dosage Form : POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
Dosage Strength : 120 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Firmagon
Dosage Form : Degarelix 120Mg 2 Units Parenteral Use
Dosage Strength : 2 vials groun 120 mg + 2 Syringes solv 3 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Firmagon
Dosage Form : Degarelix 80Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial 80 mg groun + 1 syringe solv 4,2 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Firm Agon
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 120 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Firm Agon
Dosage Form : Powder and liquid to the injection fluid, resolution
Dosage Strength : 80 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Firmagon
Dosage Form : Trockensub
Dosage Strength : 120mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Firmagon
Dosage Form : Trockensub
Dosage Strength : 80mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Australia
Brand Name : Firmagon 80mg
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Firmagon 120mg
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Firmagon 120 Mg
Dosage Form : POI
Dosage Strength : 120mg
Packaging : 3X2mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Firmagon 80 Mg
Dosage Form : POI
Dosage Strength : 80mg
Packaging : 4.2X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 80MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 120MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Global Sales Information
Dosage Form : Degarelix 120Mg 2 Units Parenter...
Dosage Strength : 2 vials groun 120 mg + 2 Syringes solv 3 m...
Price Per Pack (Euro) : 404.14
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Dosage Form : Degarelix 80Mg 1 Unit Parenteral...
Dosage Strength : 1 vial 80 mg groun + 1 syringe solv 4,2 ml
Price Per Pack (Euro) : 212.9
Published in :
Country : Italy
RX/OTC/DISCN : Class A
Dosage Form : Powder and liquid to the injecti...
Dosage Strength : 120 mg
Price Per Pack (Euro) : 279.79
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Powder and liquid to the injecti...
Dosage Strength : 80 mg
Price Per Pack (Euro) : 156.57
Published in :
Country : Norway
RX/OTC/DISCN :
Dosage Form : Trockensub
Dosage Strength : 120mg
Price Per Pack (Euro) : 245.66
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Dosage Form : Trockensub
Dosage Strength : 80mg
Price Per Pack (Euro) : 119.57
Published in :
Country : Switzerland
RX/OTC/DISCN : Class A
Market Place
Reply
09 Aug 2018
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?